What supportive peri-implant care is for
Supportive peri-implant care (SPIC) is the structured programme delivered once implants are loaded and in function — the maintenance phase that begins where active treatment ends and never formally finishes. Its purpose is preventive: to detect peri-implant mucositis while it is still reversible, to interrupt the biofilm-driven inflammatory cascade before it becomes peri-implantitis, and to catch established disease early enough that intervention is conservative rather than surgical. The evidence that this matters is unambiguous. Patients enrolled in a regular maintenance programme develop far less peri-implant disease than those who are not; non-compliance with maintenance is itself one of the strongest predictors of peri-implantitis.2 SPIC is therefore not a courtesy recall — it is the part of implant therapy that determines whether the surgical and prosthetic investment survives the decade that follows.
Two principles organize the whole chapter. First, every visit does the same set of things: it monitors (probing, bleeding, plaque, and selectively, radiographs), it debrides with implant-safe instruments, and it reinforces home care — and it always ends by setting the date of the next visit. Second, the interval is not fixed; it is read off the patient's risk profile and re-derived at each visit, because risk is dynamic.1 A patient who stops smoking, or one who develops a deep residual pocket, should not stay on the same recall they were on a year ago. The EFP S3 guideline frames maintenance exactly this way — an individualized, risk-based schedule rather than a single number applied to everyone.1
Every SPIC appointment performs four jobs in sequence. Monitor — gentle probing (~0.25 N), bleeding on probing (BOP), suppuration, plaque, and mucosal status, all compared with a recorded baseline. Debride — mechanical biofilm and calculus removal using implant-safe instruments. Reinforce — individualized oral-hygiene instruction and a check of prosthesis cleansability. Re-schedule — set the next interval from the current risk profile. If monitoring uncovers mucositis or peri-implantitis, the visit converts from supportive care to active treatment.3
What every recall visit includes
Each SPIC visit combines diagnostic monitoring with professional biofilm removal and the reinforcement of home care. The diagnostic half exists to detect change; this is why a baseline matters so much. Probing depths and a radiograph recorded at restoration delivery are the reference against which every subsequent reading is judged — an absolute probing depth of 5 mm is meaningless without knowing whether the site has always read 5 mm or has crept up from 3 mm.1 The therapeutic half exists to remove the cause: biofilm is the proximate driver of peri-implant inflammation, and its mechanical disruption is the core of maintenance.
Probing and bleeding
Peri-implant probing is performed gently — on the order of 0.25 N — at all aspects of every implant. The clinician records bleeding on probing and any suppuration, and compares probing depth against the baseline. The combination of increasing probing depth and BOP, rather than any single absolute number, is the signal that disease is establishing.1 Probing the implant is safe and should not be omitted out of a misplaced fear of damaging the mucosal seal.
Plaque and soft tissue
The clinician assesses plaque and biofilm accumulation as a direct index of home-care effectiveness, and examines the peri-implant mucosa for health, the band of keratinized tissue, and any recession. A frequently overlooked element is the prosthesis itself: an overcontoured or poorly accessible restoration that the patient physically cannot clean will defeat any hygiene instruction, and recognizing this redirects the conversation from the patient's effort to the restoration's design.
Radiographic monitoring
Imaging in SPIC is indication-driven, not interval-driven. A periapical radiograph is taken when clinical signs — increasing probing depth, BOP, suppuration — warrant it, and the marginal bone level is compared against the baseline film made at restoration delivery.1 Routine fixed-interval imaging of asymptomatic, clinically stable implants is not recommended; it adds dose without changing management.
Professional debridement
Mechanical disruption of biofilm and calculus is the therapeutic heart of the visit, and the instrument matters as much as the act. Implant surfaces must be debrided with implant-safe instruments — PEEK, titanium, or carbon-fiber tips, and air-polishing devices.3 Stainless-steel curettes and conventional metal ultrasonic tips scratch and contaminate the surface, roughening it and creating new niches for bacterial adhesion; they are contraindicated against the implant body. The visit closes with polishing and a final reinforcement of home care before dismissal.
| Component | Type | What is done | Evidence |
|---|---|---|---|
| Probing & BOP | Diagnostic | Gentle probing (~0.25 N) all sites; record BOP, suppuration, depth vs. baseline | Consensus |
| Plaque & soft tissue | Diagnostic | Plaque/biofilm index; mucosal health, keratinized tissue, recession; prosthesis access | Consensus |
| Radiographic monitoring | Diagnostic | Periapical film when clinically indicated; marginal bone level vs. baseline; no routine fixed-interval imaging | Consensus |
| Professional debridement | Therapeutic | Mechanical biofilm/calculus removal with implant-safe tips (PEEK/Ti/carbon-fiber, air-polishing); avoid steel curettes | Syst. review |
| Home-care reinforcement | Preventive | Individualized oral-hygiene instruction; verify cleansability; polish before dismissal | Syst. review |
| Risk reassessment & re-schedule | Planning | Re-derive risk; set next interval; escalate to treatment if mucositis/peri-implantitis found | Consensus |
Setting the interval from the risk profile
The single decision SPIC exists to make at the end of every visit is when to see the patient next. The defensible default is a maximum interval of about five to six months for a stable, low-risk patient — the consensus minimum frequency below which peri-implant disease risk demonstrably rises.2 From there the interval is tightened, not loosened, in the presence of risk factors. The dominant drivers are a history of periodontitis (the most robust single predictor of future peri-implant disease), smoking, inconsistent home-care compliance, and any prior peri-implant disease — to which poorly controlled diabetes and residual deep pockets are commonly added.1
The EFP S3 guideline operationalizes this for the highest-risk situation explicitly: after treatment of peri-implantitis, it advises an initial recall of about three months, then a three-to-four-month interval through the first year, individualized thereafter.1 The broader periodontal-maintenance framework spans roughly three to twelve months, tailored to the risk profile — but for implant patients the practical working range sits at the tighter end, anchored by the five-to-six-month ceiling.1 The table below maps the common drivers to an interval and an emphasis; the intervals are guides, and the final schedule is always individualized and reassessed at every visit.
| Risk factor | Recall interval | Emphasis / actions | Evidence |
|---|---|---|---|
| None — stable, healthy | ~5–6 months | Routine probing/BOP, plaque control, debridement; radiograph only if indicated | Syst. review |
| History of periodontitis | 3–4 months | Combined perio + peri-implant monitoring; reinforce interdental cleaning | Syst. review |
| Smoking | 3–4 months | Cessation counselling; close BOP / bone-level surveillance | Consensus |
| Poor home-care compliance | 3–4 months | Oral-hygiene re-instruction; assess prosthesis cleansability | Consensus |
| Prior peri-implant disease | ~3 months | Intensive surveillance; early re-intervention; treat residual pockets | Syst. review |
| Poorly controlled diabetes | ~3 months | Coordinate glycemic control; tight monitoring for inflammation | Consensus |
Interactive recall-interval selector
Stratify the patient by perio history, smoking, home-care compliance, and any prior peri-implant disease. The risk band sets the recall interval and the intensity of monitoring. Select the profile that best fits the patient to see the recommended schedule.
Re-derive the recall interval at every visit, not only at enrolment. Risk is dynamic: a patient who quits smoking, masters interdental cleaning, or achieves glycemic control has earned a longer interval; one who develops a 6 mm residual pocket, recurrent BOP, or progressive bone loss has earned a shorter one. The five-to-six-month figure is a ceiling for the lowest-risk patient, not a starting point for everyone — most implant patients with any meaningful risk factor belong at three to four months.2
- Discharging the patient to an annual or as-needed recall after restoration delivery — the single commonest, and most consequential, maintenance failure.2
- Using steel curettes or metal ultrasonic tips on the implant surface, scratching it and seeding new biofilm niches.3
- Reading an absolute probing depth without a baseline, so a stable 5 mm site triggers needless alarm while a site that has crept from 2 mm to 4 mm is missed.
- Leaving the recall interval frozen at the enrolment value while the patient's risk profile changes underneath it.
- Continuing supportive care on a site that already meets the definition of peri-implantitis — debriding a diseased implant instead of escalating to definitive treatment.
Key terms
- Supportive peri-implant care (SPIC)
- The structured maintenance programme delivered after implant loading; combines diagnostic monitoring, professional debridement, and home-care reinforcement on a risk-based recall.
- Bleeding on probing (BOP)
- Bleeding elicited by gentle probing of the peri-implant sulcus; a marker of inflammation and, with increasing probing depth, an early signal of disease.
- Peri-implant mucositis
- Reversible, biofilm-induced inflammation of the soft tissue around an implant without loss of supporting bone — the preventable precursor to peri-implantitis.
- Peri-implantitis
- Plaque-associated pathological condition featuring peri-implant mucosal inflammation with progressive loss of supporting bone.
- Implant-safe instruments
- Debridement tools that do not scratch or contaminate the titanium surface — PEEK, titanium, or carbon-fiber tips, and air-polishing devices.
- Baseline
- The reference probing depths and radiograph recorded at restoration delivery, against which all subsequent readings are compared.
- Risk-based recall
- A maintenance interval derived from, and reassessed against, the patient's individual risk profile rather than a fixed schedule.
- Compliance (adherence)
- The degree to which a patient attends scheduled maintenance and performs prescribed home care; non-compliance is a strong predictor of peri-implant disease.
Board & fellowship preparation
- Why probe at 0.25 N rather than harder?
- What single finding would make you take a radiograph today?
- What is the broad interval range the periodontal framework allows?
- When would you actually lengthen an interval?
- What happens to a scratched titanium surface microbiologically?
- Is air-polishing safe on exposed threads?
- What would move this patient into the ~3-month high-risk band?
- How would smoking cessation change your plan a year from now?
- What do you tell the patient about the cost of missing visits?
- What evidence supports a minimum maintenance frequency?
- How do you balance over-treatment burden against under-surveillance risk?
- Which risk factors are modifiable, and which are not?
References
- Herrera D, Berglundh T, Schwarz F, et al. Prevention and treatment of peri-implant diseases — The EFP S3 level clinical practice guideline. J Clin Periodontol. 2023;50(Suppl 26):4–76. doi:10.1111/jcpe.13823
- Monje A, Aranda L, Diaz KT, et al. Impact of maintenance therapy for the prevention of peri-implant diseases: a systematic review and meta-analysis. J Dent Res. 2016;95(4):372–379. doi:10.1177/0022034515622432
- Heitz-Mayfield LJA, Aaboe M, Araujo M, et al. Group 4 ITI Consensus Report: risks and biologic complications associated with implant dentistry. Clin Oral Implants Res. 2018;29(Suppl 16):351–358. doi:10.1111/clr.13307
Evidence grades: Systematic review Consensus Preclinical.